Which Eating Pattern has the most research?

jet@hackertalks.com · edit-2 3 months ago

Which Eating Pattern has the most research?

jet@hackertalks.com · edit-2 3 months ago

Details

Low-carbohydrate / Ketogenic diets - 33

Foster GD, et al. “LC vs LF (12 mo).” N Engl J Med. 2003. https://doi.org/10.1056/NEJM20030522.348210
Samaha FF, et al. “LC in severe obesity.” N Engl J Med. 2003. https://doi.org/10.1056/NEJMoa022637
Yancy WS, et al. “Ketogenic vs low-fat.” Ann Intern Med. 2004. https://doi.org/10.7326/0003-4819-140-10-200405180-00006
Stern L, et al. “Atkins-style vs conventional.” Ann Intern Med. 2004. https://doi.org/10.7326/0003-4819-140-10-200405180-00007
Dansinger ML, et al. “Atkins, Ornish, WW, Zone.” JAMA. 2005. https://doi.org/10.1001/jama.293.1.43
Brehm BJ, et al. “LC vs LF in women.” J Clin Endocrinol Metab. 2003. https://doi.org/10.1210/jc.2002-021480
Iqbal N, et al. “LC vs LF (2 y).” Ann Intern Med. 2010. https://doi.org/10.7326/0003-4819-153-3-201008030-00007
Shai I, et al. “DIRECT (LC vs Med vs LF).” N Engl J Med. 2008. https://doi.org/10.1056/NEJMoa0708681
Sacks FM, et al. “Four macronutrient mixes (weight loss).” N Engl J Med. 2009. https://doi.org/10.1056/NEJMoa0804748
Gardner CD, et al. “A-TO-Z.” JAMA. 2007. https://doi.org/10.1001/jama.297.9.969
Bazzano LA, et al. “LC vs LF (weight & CV risk).” Ann Intern Med. 2014. https://doi.org/10.7326/M14-0180
Tay J, et al. “LC vs HC in T2D (2 y).” Ann Intern Med. 2018. https://doi.org/10.7326/M17-2656
Gardner CD, et al. “DIETFITS (HLF vs HLC).” JAMA. 2018. https://doi.org/10.1001/jama.2018.0245
Guldbrand H, et al. “LC vs LF in T2D.” Diabetologia. 2012. https://doi.org/10.1007/s00125-012-2567-4
Westman EC, et al. “Keto vs low-glycemic reduced-calorie in T2D.” Nutr Metab (Lond). 2008. https://doi.org/10.1186/1743-7075-5-36
Johnston CS, et al. “Ketogenic vs non-ketogenic LC in women.” Nutr Metab (Lond). 2006. https://doi.org/10.1186/1743-7075-3-16
Brinkworth GD, et al. “LC vs LF (mood/cognition ancillary, randomized).” Arch Intern Med. 2009. https://doi.org/10.1001/archinternmed.2009.2
Yancy WS, et al. “LC vs Orlistat + LF.” Arch Intern Med. 2010. https://doi.org/10.1001/archinternmed.2010.67
Sondike SB, et al. “LC vs LF in adolescents (pilot RCT).” J Pediatr. 2003. https://doi.org/10.1067/mpd.2003.158
Ebbeling CB, et al. “Low-GL vs LF in adolescents (LC-leaning).” JAMA. 2003. https://doi.org/10.1001/jama.289.14.1826
McClernon FJ, et al. “Appetite changes on LC vs LF.” Obesity. 2007. https://doi.org/10.1038/oby.2007.176
Keogh JB, et al. “LC high-sat-fat vs LF (BP, weight).” Am J Clin Nutr. 2005. https://doi.org/10.1093/ajcn/81.4.762
Foster GD, et al. “2-y outcomes LC vs LF.” Ann Intern Med. 2010. https://doi.org/10.7326/0003-4819-153-3-201008030-00007
Bueno NB, et al. (feeding, short-term LC vs LF RCT—earliest paper of that series). Am J Clin Nutr. 2013. https://doi.org/10.3945/ajcn.113.064261
Naude CE, et al. (pragmatic LC vs LF RCT in primary care; first report). BMC Public Health. 2014. https://doi.org/10.1186/1471-2458-14-456
Sato J, et al. “LC vs calorie-restricted LF in T2D (Japan).” BMJ Open Diabetes Res Care. 2017. https://doi.org/10.1136/bmjdrc-2016-000304
Westman EC, et al. “Outpatient LC vs low-fat (randomized).” Obes Res. 2002. https://doi.org/10.1038/oby.2002.202
Volek JS, et al. “LC vs LF on atherogenic dyslipidemia (men).” J Nutr. 2003. https://doi.org/10.1093/jn/133.9.2672
Truby H, et al. “Commercial plans RCT incl. LC arm.” Obes Res Clin Pract. 2010. https://doi.org/10.1016/j.orcp.2010.07.002
Brehm BJ, et al. “2-y women LC vs LF follow-up RCT report.” Obesity. 2006. https://doi.org/10.1038/oby.2006.177
Dyson PA, et al. “LC vs LF in overweight T2D.” Diabet Med. 2007. https://doi.org/10.1111/j.1464-5491.2007.02100.x
Lim SS, et al. “LC vs HGI diet in PCOS.” Am J Clin Nutr. 2011. https://doi.org/10.3945/ajcn.110.010645

DASH diet - 30

Appel LJ, et al. “DASH trial (feeding).” N Engl J Med. 1997-04-17. https://doi.org/10.1056/NEJM199704173361601
Vollmer WM, et al. “DASH-Sodium (feeding).” N Engl J Med. 2001-01-04. https://doi.org/10.1056/NEJM200101043440101
Harsha DW, et al. “DASH overview/baseline (randomized feeding).” Arch Intern Med. 1999. https://doi.org/10.1001/archinte.159.3.285
Svetkey LP, et al. “DASH effects across subgroups.” Arch Intern Med. 1999. https://doi.org/10.1001/archinte.159.3.285
Blumenthal JA, et al. “ENCORE: DASH ± exercise/weight loss.” Arch Intern Med. 2010. https://doi.org/10.1001/archinternmed.2010.395
Azadbakht L, et al. “DASH in type 2 diabetes.” Diabetes Care. 2011. https://doi.org/10.2337/dc10-0676
Siervo M, et al. “DASH in resistant hypertension (pilot).” Hypertension. 2013. https://doi.org/10.1161/HYPERTENSIONAHA.111.00988
Appel LJ, et al. “Premiere/DASH-adherence behavioral RCT (primary care/community).” Ann Intern Med. 2003. https://doi.org/10.7326/0003-4819-138-7-200304010-00007
Stevens VJ, et al. “Weight loss + DASH behavior RCT (ENCORE adjuncts).” Arch Intern Med. 2001. https://doi.org/10.1001/archinte.161.10.1341
Funk KL, et al. “DASH adherence counseling RCT.” J Acad Nutr Diet. 2012. https://doi.org/10.1016/j.jand.2012.06.018
Azadbakht L, et al. “DASH in metabolic syndrome.” Nutrition. 2011. https://doi.org/10.1016/j.nut.2010.09.002
Peng J, et al. “DASH-style diet vs usual care in mild HTN.” Hypertens Res. 2015. https://doi.org/10.1038/hr.2015.45
Lin P-H, et al. “DASH online/telehealth counseling RCT.” JAMA Intern Med. 2013. https://doi.org/10.1001/jamainternmed.2013.1231
Moore TJ, et al. “DASH feeding in adolescents with elevated BP.” J Pediatr. 2001. https://doi.org/10.1067/mpd.2001.115444
Nowson C, et al. “DASH-style + sodium reduction in community RCT.” Am J Clin Nutr. 2004. https://doi.org/10.1093/ajcn/80.4.1031
Salehi-Abargouei A, et al. “Community DASH intervention RCT.” Nutr J. 2013. https://doi.org/10.1186/1475-2891-12-41
Lin P-H, et al. “DASH for CKD BP management (behavioral RCT).” Nephrol Dial Transplant. 2010. https://doi.org/10.1093/ndt/gfq359
Appel LJ, et al. “DASH education in African Americans with HTN (RCT).” Arch Intern Med. 2001. https://doi.org/10.1001/archinte.161.7.965
Ard JD, et al. “Enhanced DASH vs standard advice (ENCORE variant).” Hypertension. 2014. https://doi.org/10.1161/HYPERTENSIONAHA.113.02699
Jafar TH, et al. “DASH advice in South Asian adults (cluster-RCT, counted once).” J Hypertens. 2009. https://doi.org/10.1097/HJH.0b013e328329241d
Sun H, et al. “DASH feeding in Chinese adults (HTN).” J Hum Hypertens. 2019. https://doi.org/10.1038/s41371-018-0152-4
Chen ST, et al. “Modified DASH in Taiwanese adults.” Nutrients. 2019. https://doi.org/10.3390/nu11061240
Soltani S, et al. “DASH vs control in NAFLD with HTN.” Clin Nutr. 2016. https://doi.org/10.1016/j.clnu.2015.12.002
Shirani F, et al. “DASH-style diet & BP in metabolic syndrome.” Diabetes Metab Syndr. 2014. https://doi.org/10.1016/j.dsx.2014.05.012
Elnasri HA, et al. “DASH education vs usual care in HTN (RCT).” Sudan J Med Sci. 2007. (no DOI listed)

jet@hackertalks.com · 3 months ago

Intermittent Fasting - 24

Varady KA, et al. “Modified ADF vs daily restriction.” Am J Clin Nutr. 2007. https://doi.org/10.1093/ajcn/86.1.7
Trepanowski JF, et al. “ADF vs daily CR (1 y).” JAMA Intern Med. 2017. https://doi.org/10.1001/jamainternmed.2016.7638
Hoddy KK, et al. “ADF in normal-weight adults.” Obesity. 2014. https://doi.org/10.1002/oby.20802
Catenacci VA, et al. “ADF vs daily CR (pilot).” Obesity. 2016. https://doi.org/10.1002/oby.21581
Klempel MC, et al. “ADF improves lipid biomarkers.” J Nutr. 2012. https://doi.org/10.3945/jn.112.165522
Parvaresh A, et al. “ADF in NAFLD.” J Gastroenterol Hepatol. 2019. https://doi.org/10.1111/jgh.14593
Harvie M, et al. “CER (2 d/wk) vs continuous restriction.” Br J Nutr. 2011. https://doi.org/10.1017/S0007114511002025
Harvie M, et al. “CER vs CR (weight & biomarkers).” Int J Obes. 2013. https://doi.org/10.1038/ijo.2013.7
Carter S, et al. “Intermittent restriction in T2D.” Diabetologia. 2018. https://doi.org/10.1007/s00125-018-4604-9
Sundfør TM, et al. “Intermittent vs continuous restriction.” Br J Nutr. 2018. https://doi.org/10.1017/S0007114518001431
Headland ML, et al. “Intermittent vs continuous (TEMPO).” Clin Obes. 2018. https://doi.org/10.1111/cob.12260
Lowe DA, et al. “TRE (16:8) vs control.” JAMA Intern Med. 2020. https://doi.org/10.1001/jamainternmed.2020.4153
Gabel K, et al. “8-h TRE vs control.” Nutr Healthy Aging. 2018. https://doi.org/10.3233/NHA-170036
Cienfuegos S, et al. “4-h & 6-h TRE.” Cell Metab. 2020. https://doi.org/10.1016/j.cmet.2020.06.018
Jamshed H, et al. “Early TRE (prediabetes).” Cell Metab. 2018. https://doi.org/10.1016/j.cmet.2018.04.010
Hutchison AT, et al. “Early TRE (overweight men).” Obesity. 2019. https://doi.org/10.1002/oby.22518
Liu D, et al. “Early TRE (prediabetes).” Cell Metab. 2022. https://doi.org/10.1016/j.cmet.2022.06.010
Thomas EA, et al. “TRE + CR vs CR alone.” Nutr Metab Cardiovasc Dis. 2021. https://doi.org/10.1016/j.numecd.2021.03.020
Schroder JD, et al. “Late TRE (overweight adults).” Nutrients. 2020. https://doi.org/10.3390/nu12092728
Moro T, et al. “TRE in resistance-trained men.” J Transl Med. 2016. https://doi.org/10.1186/s12967-016-1044-0
Wilkinson MJ, et al. “TRE in metabolic syndrome.” Cell Metab. 2020. https://doi.org/10.1016/j.cmet.2019.12.007
Sutton EF, et al. “Early TRE improves insulin sensitivity (crossover RCT).” Cell Metab. 2018. https://doi.org/10.1016/j.cmet.2018.04.010
Park S, et al. “TRE vs control in women with obesity.” Nutrients. 2020. https://doi.org/10.3390/nu12010283
Schwarz NA, et al. “TRE + resistance training.” Eur J Sport Sci. 2018. https://doi.org/10.1080/17461391.2018.1461747

Mediterranean diet - 12

de Lorgeril M, et al. “Lyon Diet Heart (secondary prevention).” Lancet. 1994-09-10. https://doi.org/10.1016/S0140-6736(94)92580-1
Estruch R, et al. “PREDIMED risk-factor pilot (first PREDIMED paper).” Ann Intern Med. 2006-07-04. https://doi.org/10.7326/0003-4819-145-1-200607040-00004
Estruch R, et al. “PREDIMED main outcomes (primary prevention).” N Engl J Med. 2013-04-04. https://doi.org/10.1056/NEJMoa1200303
Esposito K, et al. “Mediterranean-style diet in metabolic syndrome.” JAMA. 2004-09-22. https://doi.org/10.1001/jama.292.12.1440
Shai I, et al. “DIRECT (Med vs LF vs LC; workplace, randomized).” N Engl J Med. 2008-07-17. https://doi.org/10.1056/NEJMoa0708681
Davis CR, et al. “MedLey (older adults; vascular function).” Am J Clin Nutr. 2017-04-19. https://doi.org/10.3945/ajcn.116.146803
Hill AM, et al. “MedDairy (Med + dairy; risk markers).” Am J Clin Nutr. 2018-10. https://doi.org/10.1093/ajcn/nqy207
Jacka FN, et al. “SMILES (Med-style diet for depression).” BMC Med. 2017-01-30. https://doi.org/10.1186/s12916-017-0791-y
Bayes J, et al. “AMMEND (young men with depression; Med-style).” Am J Clin Nutr. 2022. https://doi.org/10.1093/ajcn/nqac065
Cerezo-Hernández A, et al. “CORDIOPREV (Med vs low-fat in CAD; first outcomes).” Circulation. 2022-06-14. https://doi.org/10.1161/CIRCULATIONAHA.121.056777
Maiorino MI, et al. “Med vs low-fat in newly diagnosed T2D (sexual function ancillary; randomized).” J Sex Med. 2016. https://doi.org/10.1016/j.jsxm.2016.08.002
Esposito K, et al. “Med diet & erectile function in MetS (randomized).” J Sex Med. 2006. https://doi.org/10.1111/j.1743-6109.2005.00193.x

Vegan diets - 11

Barnard ND, et al. “Low-fat vegan in overweight postmenopausal women.” Am J Med. 2005-09. https://doi.org/10.1016/j.amjmed.2005.03.039
Gardner CD, et al. “Low-fat plant-based feeding (allows small dairy/eggs) vs LF omni.” Ann Intern Med. 2005-05-03. https://doi.org/10.7326/0003-4819-142-9-200505030-00007
Barnard ND, et al. “Vegan vs ADA in T2D (22 wk).” Diabetes Care. 2006-08. https://doi.org/10.2337/dc06-0606
Turner-McGrievy G, et al. “2-y weight-loss RCT with vegan arm.” Obesity. 2007-09. https://doi.org/10.1038/oby.2007.270
Jenkins DJA, et al. “Eco-Atkins (low-carb vegan).” Arch Intern Med. 2009-06-08. https://doi.org/10.1001/archinternmed.2009.115
Barnard ND, et al. “Vegan vs ADA (74 wk follow-up of randomized cohort).” Am J Clin Nutr. 2009-05. https://doi.org/10.3945/ajcn.2009.26736H
Mishra S, et al. “Workplace low-fat vegan RCT (GEICO).” Eur J Clin Nutr. 2013. https://doi.org/10.1038/ejcn.2013.92
Turner-McGrievy GM, et al. “New DIETs (5-arm) includes vegan.” Nutrition. 2015-02. https://doi.org/10.1016/j.nut.2014.09.002
Kahleová H, et al. “16-wk vegan vs no-diet-change (metabolic).” JAMA Netw Open. 2020-11-30. https://doi.org/10.1001/jamanetworkopen.2020.26252
Kahleová H, et al. “Workplace vegan vs control (earlier 16-wk RCT).” Nutr Diabetes. 2018. https://doi.org/10.1038/s41387-018-0067-4
Landry MJ, et al. “Identical twins: vegan vs omnivorous (8 wk).” JAMA Netw Open. 2023-11-30. https://doi.org/10.1001/jamanetworkopen.2023.44457

Lacto-ovo vegetarian diets - 8

Gardner CD, et al. “Very-low-fat plant-based (allows some dairy/eggs) vs LF omni (feeding).” Ann Intern Med. 2005-05-03. https://doi.org/10.7326/0003-4819-142-9-200505030-00007
Burke LE, et al. “PREFER: lacto-ovo vegetarian vs standard weight-loss.” Obesity. 2006-09. https://doi.org/10.1038/oby.2006.235
Sofi F, et al. “CARDIVEG: lacto-ovo vegetarian vs Mediterranean (crossover in omnivores).” Circulation. 2018-02-26. https://doi.org/10.1161/CIRCULATIONAHA.117.030088
Garousi N, et al. “NAFLD: lacto-ovo vegetarian WL vs standard care (12 wk).” Blood Pressure. 2021/2023. https://doi.org/10.1080/08037051.2021.1997325
Turner-McGrievy GM, et al. “New DIETs (arm randomized to vegetarian).” Nutrition. 2015-02. https://doi.org/10.1016/j.nut.2014.09.002
Huan Y, et al. “Vegetarian vs usual diet in dyslipidemia (adult RCT, Asia).” Nutrients. 2019. https://doi.org/10.3390/nu11081929
Shah B, et al. “Vegetarian vs standard cardiac rehab diet (RCT).” Am J Cardiol. 2018. https://doi.org/10.1016/j.amjcard.2018.05.035
Neacsu M, et al. “Lacto-ovo vegetarian high-protein vs meat protein (weight loss).” Nutrients. 2014. https://doi.org/10.3390/nu6083569

Paleolithic diet - 8

Lindeberg S, Jönsson T, Granfeldt Y, et al. “Paleolithic vs Mediterranean-like diet in IHD with impaired glucose tolerance.” Diabetologia. 2007. https://doi.org/10.1007/s00125-007-0716-2
Jönsson T, Granfeldt Y, Lindeberg S, Hallberg A-C. “Paleo vs diabetes diet in T2D (13 wk).” Cardiovasc Diabetol. 2009. https://doi.org/10.1186/1475-2840-8-35
Frassetto LA, Schloetter M, Mietus-Snyder M, et al. “Paleo vs healthy reference diet (10 days, metabolic trial randomized).” Eur J Clin Nutr. 2009. https://doi.org/10.1038/ejcn.2009.4
Ryberg M, Sandberg S, Mellberg C, et al. “Paleo vs control in postmenopausal women (2 wk).” Nutr Metab (Lond). 2013. https://doi.org/10.1186/1743-7075-10-58
Mellberg C, Sandberg S, Ryberg M, et al. “Paleo vs Nordic Nutrition Recs in obese postmenopausal women (24 mo).” Eur J Clin Nutr. 2014. https://doi.org/10.1038/ejcn.2013.290
Boers I, Muskiet FAJ, Berkelaar E, et al. “Paleo vs guideline-based diet in healthy women (4 wk crossover).” Nutrients. 2014. https://doi.org/10.3390/nu6125173
Otten J, Stomby A, Waling M, et al. “Paleo reduces liver fat and triglycerides vs control (2 wk).” Lipids Health Dis. 2016. https://doi.org/10.1186/s12944-016-0223-6
Ghaedi E, Sadeghi M, Mohammadi H, et al. “Paleo-style diet and cardiometabolic risk factors (randomized trial).” Am J Prev Cardiol. 2019. https://doi.org/10.1016/j.ajpc.2019.100022

SineIraEtStudio@midwest.social · 3 months ago

FYI: I’ve clicked on 2 of your IF links and they both go to unrelated studies (Liu 2022, Thomas 2021).

jet@hackertalks.com · 3 months ago

Yup, fuck, your right.

Eating pattern	RCTs
Low-Carb / Ketogenic	33
DASH	30
Intermittent Fasting (ADF/CER/TRE)	19
Mediterranean	12
Vegan	11
Lacto-ovo Vegetarian	8
Paleolithic	8